Literature DB >> 31436539

Understanding Peptide Binding in Class A G Protein-Coupled Receptors.

Irina G Tikhonova1, Veronique Gigoux2, Daniel Fourmy2.   

Abstract

Many physiologic processes are controlled through the activation of G protein-coupled receptors (GPCRs) by regulatory peptides, making peptide GPCRs particularly useful targets for major human diseases such as diabetes and cancer. Peptide GPCRs are also being evaluated as next-generation targets for the development of novel antiparasite agents and insecticides in veterinary medicine and agriculture. Resolution of crystal structures for several peptide GPCRs has advanced our understanding of peptide-receptor interactions and fueled interest in correlating peptide heterogeneity with receptor-binding properties. In this review, the knowledge of recently crystalized peptide-GPCR complexes, previously accumulated peptide structure-activity relationship studies, receptor mutagenesis, and sequence alignment are integrated to better understand peptide binding to the transmembrane cavity of class A GPCRs. Using SAR data, we show that peptide class A GPCRs can be divided into groups with distinct hydrophilic residues. These characteristic residues help explain the preference of a receptor to bind the C-terminal free carboxyl group, the C-terminal amidated group, or the N-terminal ammonium group of peptides.
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31436539      PMCID: PMC6776014          DOI: 10.1124/mol.119.115915

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  113 in total

1.  Structure-Activity Study of Ghrelin(1-8) Resulting in High Affinity Fluorine-Bearing Ligands for the Ghrelin Receptor.

Authors:  Carlie L Charron; Jinqiang Hou; Mark S McFarland; Savita Dhanvantari; Michael S Kovacs; Leonard G Luyt
Journal:  J Med Chem       Date:  2017-08-24       Impact factor: 7.446

2.  Evidence that interspecies polymorphism in the human and rat cholecystokinin receptor-2 affects structure of the binding site for the endogenous agonist cholecystokinin.

Authors:  Ingrid Langer; Irina G Tikhonova; Marie-Agnès Travers; Elodie Archer-Lahlou; Chantal Escrieut; Bernard Maigret; Daniel Fourmy
Journal:  J Biol Chem       Date:  2005-04-07       Impact factor: 5.157

3.  A structure function study of C-terminal extensions of bombesin.

Authors:  M Mervic; T W Moody; A Komoriya
Journal:  Peptides       Date:  1991 Sep-Oct       Impact factor: 3.750

Review 4.  Gastrin agonists and antagonists.

Authors:  James W Black; S Barret Kalindjian
Journal:  Pharmacol Toxicol       Date:  2002-12

5.  Stimulus-response coupling in neurohypophysial peptide target cells.

Authors:  S Jard; J Bockaert
Journal:  Physiol Rev       Date:  1975-10       Impact factor: 37.312

6.  Effect of single point mutations of the human tachykinin NK1 receptor on antagonist affinity.

Authors:  K Lundstrom; A B Hawcock; A Vargas; P Ward; P Thomas; A Naylor
Journal:  Eur J Pharmacol       Date:  1997-10-15       Impact factor: 4.432

7.  Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.

Authors:  M Sautel; K Rudolf; H Wittneben; H Herzog; R Martinez; M Munoz; W Eberlein; W Engel; P Walker; A G Beck-Sickinger
Journal:  Mol Pharmacol       Date:  1996-08       Impact factor: 4.436

8.  ASP147 in the third transmembrane helix of the rat mu opioid receptor forms ion-pairing with morphine and naltrexone.

Authors:  J G Li; C Chen; J Yin; K Rice; Y Zhang; D Matecka; J K de Riel; R L DesJarlais; L Y Liu-Chen
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

9.  Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine.

Authors:  Ling Qin; Irina Kufareva; Lauren G Holden; Chong Wang; Yi Zheng; Chunxia Zhao; Gustavo Fenalti; Huixian Wu; Gye Won Han; Vadim Cherezov; Ruben Abagyan; Raymond C Stevens; Tracy M Handel
Journal:  Science       Date:  2015-01-22       Impact factor: 47.728

10.  Delineation of the peptide binding site of the human galanin receptor.

Authors:  K Kask; M Berthold; U Kahl; G Nordvall; T Bartfai
Journal:  EMBO J       Date:  1996-01-15       Impact factor: 11.598

View more
  6 in total

1.  Understanding the molecular mechanism of endothelin ETA receptor selecting isopeptides endothelin-1 and -3.

Authors:  Lingyun Wang; Lingling Wang; Feng Yan
Journal:  Biophys J       Date:  2022-06-06       Impact factor: 3.699

2.  Cloning of the first cDNA encoding a putative CCRFamide precursor: identification of the brain, eyestalk ganglia, and cardiac ganglion as sites of CCRFamide expression in the American lobster, Homarus americanus.

Authors:  J Joe Hull; Melissa A Stefanek; Patsy S Dickinson; Andrew E Christie
Journal:  Invert Neurosci       Date:  2020-11-26

3.  When Macrocyclic Peptides Meet the Crystal Structure of a Melanocortin Receptor.

Authors:  Paolo Grieco
Journal:  J Med Chem       Date:  2021-01-04       Impact factor: 7.446

Review 4.  The Structural Basis of Peptide Binding at Class A G Protein-Coupled Receptors.

Authors:  Oanh Vu; Brian Joseph Bender; Lisa Pankewitz; Daniel Huster; Annette G Beck-Sickinger; Jens Meiler
Journal:  Molecules       Date:  2021-12-30       Impact factor: 4.411

5.  The effect of substance P and its common in vivo-formed metabolites on MRGPRX2 and human mast cell activation.

Authors:  Lin Hsin; Nithya A Fernandopulle; Jie Ding; Chris Lumb; Nicholas Veldhuis; John A Karas; Susan E Northfield; Graham A Mackay
Journal:  Pharmacol Res Perspect       Date:  2022-08

6.  AI protein structure prediction-based modeling and mutagenesis of a protostome receptor and peptide ligands reveal key residues for their interaction.

Authors:  Shi-Qi Guo; Ya-Dong Li; Ping Chen; Guo Zhang; Hui-Ying Wang; Hui-Min Jiang; Wei-Jia Liu; Ju-Ping Xu; Xue-Ying Ding; Ping Fu; Ke Yu; Hai-Bo Zhou; James W Checco; Jian Jing
Journal:  J Biol Chem       Date:  2022-08-30       Impact factor: 5.486

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.